Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Soliman Abdul Kader Fakeeh Hospital Co's revenue for the
three
months ended in Jun. 2026 was ﷼799 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼3,100 Mil.
Dr Soliman Abdul Kader Fakeeh Hospital Co's Revenue per Share for the
three
months ended in Jun. 2026 was ﷼3.45.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼13.44.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Dr Soliman Abdul Kader Fakeeh Hospital Co Revenue Related Terms
Dr Soliman Abdul Kader Fakeeh Hospital Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co Revenue Chart
Dr Soliman Abdul Kader Fakeeh Hospital Co Annual Data
Trend
Dec23
Dec24
Dec25
Revenue
2,326.69
2,790.88
3,090.25
Dr Soliman Abdul Kader Fakeeh Hospital Co Quarterly Data
For the Medical Care Facilities subindustry, Dr Soliman Abdul Kader Fakeeh Hospital Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Soliman Abdul Kader Fakeeh Hospital Co Revenue vs Healthcare Providers & Services Industry
Dr Soliman Abdul Kader Fakeeh Hospital Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼3,100 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a Revenue of ﷼3,100 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co's Revenue too high?
Dr Soliman Abdul Kader Fakeeh Hospital Co's current Revenue is ﷼3,100 Mil. Overall, Dr Soliman Abdul Kader Fakeeh Hospital Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Dr Soliman Abdul Kader Fakeeh Hospital Co's Revenue compare to HCA and THC?
Dr Soliman Abdul Kader Fakeeh Hospital Co's Revenue of ﷼3,100 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. Dr Soliman Abdul Kader Fakeeh Hospital Co's current Revenue is ﷼3,100 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co stock overvalued right now?
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a current Revenue of ﷼3,100 Mil. The current Revenue is ﷼3,100 Mil. Dr Soliman Abdul Kader Fakeeh Hospital Co's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017), the current Revenue is ﷼3,100 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Soliman Abdul Kader Fakeeh Hospital Co is a company whose principal activities include managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. In addition to the above, the company is also managing and operating medical services, analysis and radiology laboratory, and managing and establishing pharmacies, wholesale and retail of medical equipment, maintenance of IT equipment, and software-related services. The group has three reportable segments, including medical services, which generates maximum revenue, education, trading, retail, and others. Geographically, it principally operates in the Kingdom of Saudi Arabia.
15GF Score
Get the complete analysis for SAU:4017
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4017 has been successfully added to your 
